March 13, 2024
Newly engineered molecule bypasses toxicity previously found in key cancer-fighting pathway
UNC Lineberger researchers have developed a molecule that is much more effective than a previously identified molecule at activating a biological pathway and spurring a strong anti-cancer immune response in preclinical studies.